Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 10, 2009
Grant Date -
Jul 27, 2006
app pub date -
Sep 12, 2003
filing date -
Sep 12, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
An objective of the present invention is to provide compounds having Rho kinase inhibitory activity and useful for the treatment of diseases mediated by Rho kinase. The compounds according to the present invention are those represented by formula (I) or pharmaceutically acceptable salts or solvates thereof:wherein Q represents phenyl, pyridyl, pyrrolyl, thienyl, or furyl; these groups are optionally substituted by one or two halogens or alkyl, nitro, or amino groups; and p is 2 or 3.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully